Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Prescription medicine bottle and oral syringe for baby isolated on blue background | Image Credit: © nd700 - stock.adobe.com

Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care

ByLaura Owens,Yeli Zhang

October 7th 2025

Human head | Image Credit: © ShpilbergStudios - © ShpilbergStudios - stock.adobe.com

Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs

ByFeliza Mirasol

October 7th 2025

robot used in drug discovery | Image Credit: © Caleb Foster - © Caleb Foster - stock.adobe.com

Process-Specific HCP ELISA Highlights Trend Toward Tailored Biopharma Analytics

ByFeliza Mirasol

October 3rd 2025

White House, Pfizer Reach First MFN Pricing Agreement; Who's Next?

ByPatrick Lavery

September 30th 2025

Global Biologics Manufacturing Excellence across Quality, Efficiency, and CoGs

ByWuXi Biologics

September 30th 2025

Single-Use Technology in Downstream Processing

Articles in this issue

Newsletter

Related Content

Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care

Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs

Process-Specific HCP ELISA Highlights Trend Toward Tailored Biopharma Analytics

White House, Pfizer Reach First MFN Pricing Agreement; Who's Next?

Global Biologics Manufacturing Excellence across Quality, Efficiency, and CoGs

Trending on BioPharm International

Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs

How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia

Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care

$1.8M RedHill Deal Highlights Growing Worldwide Focus on H. pylori Treatment Access